64 results about "Ginsenoside Rb1" patented technology

The invention relates to the technical field of exosomes, in particular to an exosome compound preparation with a hair growing effect and a preparation method of the exosome compound preparation. Comprising 12 to 22 parts of ginsenoside Rb1, 15 to 12 parts of biotin tripeptide-15, 8 to 15 parts of diammonium glycyrrhizinate, 50 to 70 parts of fish collagen peptide, 10 to 20 parts of soybean peptide, 0.5 to 4.5 parts of SHH protein, 0.5 to 2.5 parts of SMO inhibitor, 0.5 to 1.5 parts of HhSP protein, 5 to 10 parts of N-acetyl tyrosine, 0.1 to 2 parts of hyaluronic acid, 0.1 to 1 part of melatonin, 0.1 to 1 part of quercetin, 0.1 to 1 part of kaempferol, 0.1 to 1 part of tanshinone, 0.1 to 1 part of biotin and 0.1 to 1 part of vitamin A. The compound preparation is combined with exosomes from various sources, so that the hair papilla cell function is synergistically enhanced, and the damaged hair follicle structure is repaired.

The invention provides a cobalt monatomic nano-enzyme system modified by phospholipid polyethylene glycol carboxyl. The cobalt monatomic nano-enzyme system comprises a cobalt monatomic nano-enzyme composite core and phospholipid polyethylene glycol carboxyl compounded on the surface of cobalt monatomic nano-enzyme, the cobalt monatomic nano-enzyme composite core comprises a cobalt monatomic nano-enzyme and ginsenoside loaded on the cobalt monatomic nano-enzyme. The invention also provides a bifidobacterium synergetic cobalt monatomic nano-enzyme system which is formed by combining cobalt monatomic nano-enzyme with ginsenoside Rb1 and further delivering the cobalt monatomic nano-enzyme and ginsenoside Rb1 through bifidobacterium bifidum for targeted therapy of enteritis. The combination of Co SA and Rb1 can enhance the anti-inflammatory efficacy by adjusting a key immune signal pathway, and bifidobacterium bifidum can ensure targeted delivery of microbiota and promote intestinal barrier repair. The synergistic three-component strategy integrating monatomic nano-enzyme antioxidation, natural drug immunoregulation and probiotic targeting is provided, and a promising treatment platform is provided for accurate intervention of IBD.

The present invention relates to a functional cosmetic composition comprising plant exosomes derived from ginseng as an active ingredient and a functional cosmetic containing the same. Ginseng exosomes have a bilipid layer structure and are rich in ginsenosides Rb1 and Rg1, which influence skin improvement and whitening. It has been proven that these powerful functional materials, ginsenosides Rb1 and Rg1, are absorbed in large quantities through ginseng exosomes into skin cells, enhance the synthesis of collagen and hyaluronic acid in skin cells, and have the efficacy of inhibiting melanin synthesis. Therefore, the ginseng exosomes rich in ginsenosides Rb1 and Rg1, presented in the present invention, can be beneficially used in functional cosmetic compositions for skin aging prevention, skin whitening, wrinkle improvement and skin cell regeneration.

The invention relates to a strain of Lactobacillus coryniformis ZS-07 and an application of the Lactobacillus coryniformis ZS-07 in preparation of rare ginsenoside through fermentation, and belongs to the field of microbial fermentation, the Lactobacillus coryniformis ZS-07 is preserved in China Center for Type Culture Collection on January 4, 2026, and the preservation number of the Lactobacillus coryniformis ZS-07 is CCTCC NO: M 2026009. According to the invention, ginsenoside Rb1 is used as a raw material, and the rare ginsenosides 20 (S)-Rg3, 20 (R)-Rg3, Rk1 and Rg5 are prepared by fermentation and conversion of Lactobacillus coryniformis ZS-07. The preparation method comprises the following steps: preparing the rare ginsenosides 20 (S)-Rg3, 20 (R)-Rg3, 20 (R)-Rg3, Rk1 and Rg5; the ginsenoside Rb1 can be converted into 20 (S)-Rg3, 20 (R)-Rg3, Rk1 and Rg5 after fermentation, and different from conventional methods depending on alkaline hydrolysis, high temperature and high pressure or steam treatment, the process shows the advantages of excellent mild characteristic, environmental friendliness and low cost, and the content of converted products can be effectively increased. The invention constructs a new strategy for directional synthesis of rare ginsenosides 20 (S)-Rg3, 20 (R)-Rg3, Rk1 and Rg5, thereby widening the application prospect and industrialization potential of the rare ginsenosides 20 (S)-Rg3, 20 (R)-Rg3, Rk1 and Rg5.

The invention relates to the technical field of food, in particular to a composition for relieving anxiety and improving sleep and a preparation method and application thereof, and the composition is composed of jujuboside, anthocyanin, gamma-aminobutyric acid and ginsenoside Rb1. The jujuboside is derived from spina date seeds, the anthocyanin is derived from at least one of lycium ruthenicum, blueberry purple epidermis, aronia melanocarpa and mulberries, and the ginsenoside Rb1 is derived from at least one of ginseng roots, ginseng stems and leaves, ginseng flowers, panax notoginseng roots, panax notoginseng stems and leaves, panax notoginseng flowers, panax notoginseng fibrous roots and American ginseng. According to the invention, a plurality of components are synergistic, the efficacy is comprehensive and the pertinence is strong, the effective components are not simply mixed, but form a highly synergistic action system, and the efficacy covers multiple dimensions of improving sleep, relieving anxiety and improving the overall state.

The invention relates to the technical field of gene engineering and enzyme engineering, in particular to a beta-glucosidase mutant with high catalytic activity and application of the beta-glucosidase mutant. The sequence of the beta-glucosidase mutant is obtained by carrying out any one of the following mutations on an amino acid sequence as shown in SEQ ID No.1: respectively mutating proline at the 95th site and arginine at the 178th site into cysteine; phenylalanine at the 98th site and arginine at the 178th site are respectively mutated into cysteine. The obtained mutants P95C / R178C and F98C / R178C have high enzyme activity, ginsenoside Rb1 can be converted into CK, the conversion efficiency is respectively improved by 83.52% and 105.79% compared with that of wild beta-glucosidase, and the industrial application of enzymatic conversion of rare ginsenoside CK is promoted.

The invention discloses Dubosiella Newyorkens TZF-001 capable of producing beta-glucosidase and application of the Dubosiella Newyorkens TZF-001 in preparation of ginsenoside through fermentation and conversion, and belongs to the field of probiotic fermentation. The Dubosiella Newyorkens TZF-001 is preserved in the China Center for Type Culture Collection on December 15, 2025, and the preservation number of the Dubosiella Newyorkens TZF-001 is CCTCC (China Center for Type Culture Collection) NO: M20252889. According to the invention, ginsenoside Rb1 is used as a raw material, and Dubosiella Newyorkens TZF-001 with high yield of beta-glucosidase is used for fermentation and conversion of ginsenoside so as to prepare ginsenoside Rd. The ginsenoside Rb1 can be completely converted into Rd after fermentation, the dependence of a traditional method on acid-base hydrolysis, high temperature and high pressure and steam treatment is avoided, the reaction condition is mild, and the method has the advantages of being environmentally friendly, low in cost, high in product purity and the like. The method opens up a brand new technical path for green and low-cost preparation of ginsenoside Rd, and has remarkable innovativeness and popularization value in the field of industrialization of active ingredients of natural medicines.

The invention provides a nerve soothing and mind stabilizing pill and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine preparations. The preparation method comprises the following steps: cleaning, infiltrating, cutting, drying, performing high-pressure steam sterilization on genuine medicinal materials such as poria cocos, poria with hostwood, ginseng, polygala tenuifolia, rhizoma acori graminei and the like in a formula of the mind-tranquilizing and mind-tranquilizing pill, mixing and crushing at low temperature to obtain fine powder, adding refined honey to prepare pills, and finally coating with cinnabar powder to obtain the mind-tranquilizing and mind-tranquilizing pill. The contents of polygala-ketone III, 3, 6 '-dimustard acyl sucrose, ginsenoside Rb1, beta-asarone, dehydrotumoic acid, pachymic acid and calcium salt in the prepared nerve-soothing and mind-stabilizing pill are high, the loss of index components in the pelleting process is small, and the dissolution time limit and microbial limit of the pill meet the requirements of Chinese Pharmacopoeia of 2025 edition. The preparation process of the mind-tranquilizing and mind-stabilizing pill is stable, and the prepared mind-tranquilizing and mind-stabilizing pill can effectively improve cognitive impairment, inflammation and oxidative stress injury caused by insomnia.

The invention discloses application of combination of ginsenoside Rb1 and luteolin in prevention and treatment of male reproductive toxicity caused by organophosphorus pesticides, and belongs to the field of medicines. A high-toxicity organophosphorus pesticide glyphosate is used as a representative, the reproductive toxicity effect of the glyphosate on male mice and the relieving effect of the ginsenoside Rb1 and the composition of the ginsenoside Rb1 and the luteolin on the male reproductive toxicity of the glyphosate are observed through tests, and the result shows that the ginsenoside Rb1 and the luteolin composition have the effect of inhibiting the reproductive toxicity of the glyphosate. The ginsenoside Rb1 and the composition of the ginsenoside Rb1 and the luteolin have a remarkable relieving effect on male reproductive toxic diseases caused by organophosphorus pesticides, wherein the male reproductive toxic diseases comprise testis diseases and sperm malformation rate increase, and antioxidant index GSH decrease and T-SOD increase caused by the organophosphorus pesticides. Effective drugs and treatment strategies are provided for preventing and treating organophosphorus pesticide induced male reproductive toxicity and diseases induced by organophosphorus pesticide induced male reproductive toxicity.

The invention belongs to the technical field of food processing and biological medicines, and relates to a ginsenoside Rb1-lactoferrin composite emulsion with an anti-inflammatory effect and a preparation method thereof. The emulsion is prepared from the following components in parts by weight: 0.1 part of ginsenoside Rb1-lactoferrin complex, 7.5 to 8.5 parts of peanut oil and 1.4 to 2.4 parts of water. The emulsion disclosed by the invention has better stability, bioaccessibility and anti-inflammatory activity, does not have unstable phenomena such as layering and the like after being stored at room temperature for 35 days, and has a wide application prospect in food and pharmaceutical industries.

The invention discloses a method for detecting notoginsenoside R1, ginsenoside Rg1 and ginsenoside Rb1 in a heart-stabilizing composition.The method comprises the steps of preparation of a reference solution, preparation of a test solution and determination through a high performance liquid chromatography. The notoginsenoside R1, the ginsenoside Rg1 and the ginsenoside Rb1 can be detected at the same time, the separation effect of the notoginsenoside Rb1 is good, and a new alternative method is provided.

The application provides a composition for improving intestinal digestive enzyme activity and application thereof, and belongs to the technical field of animal medicine. The composition is composed of double-kidney polysaccharide, ginsenoside Rb1 and ginsenoside Rg1. In the composition, the mass ratio of the double-kidney polysaccharide, the ginsenoside Rb1 and the ginsenoside Rg1 is 90:5:5 or 95:2.5:2.5, preferably 90:5:5, and the intestinal digestive enzyme is specifically duodenal trypsin and amylase. Experimental results show that the composition can significantly synergistically improve the activities of the duodenal trypsin and amylase of laying hens, improve the feed utilization rate, thereby improve the egg production rate, improve the egg weight and the eggshell strength, and effectively improve the breeding benefit of the laying hens.

The invention provides application of pediococcus acidilactici and red ginseng fermented by the pediococcus acidilactici in oral anti-aging efficacy, and relates to the technical field of biological fermentation, the pediococcus acidilactici is pediococcus acidilactici, the strain number of the pediococcus acidilactici is KMHD9-314, the registration number of the pediococcus acidilactici in the China General Microbiological Culture Collection Center is CGMCC No.32357, and the preservation number of the pediococcus acidilactici is KMHD9-314. According to the pediococcus acidilactici KMHD9-314, ginsenosides Rb1, Rb2, Rc, Rf and Re can be converted into rare ginsenosides 20 (S)-Rg3, 20 (R)-Rg3, Rk1, Rg5, Rh1, Rg6, Rh4 and Rk3, and the total amount of the rare ginsenosides is increased. The technical problem that in the prior art, the efficiency of converting rare ginsenoside through microbial fermentation is low is solved.

The invention relates to the technical field of health-care food, in particular to a pseudo-ginseng oral liquid and a preparation method and application thereof, and the pseudo-ginseng oral liquid comprises the following components in percentage by weight: 20-40% of pseudo-ginseng root extract, 3-8% of pseudo-ginseng stem and leaf extract, 0.5-2% of pseudo-ginseng flower extract and the balance of purified water. The total saponin is not less than 1200 mg / 100 mL in terms of ginsenoside Re, the ginsenoside Rb1 is not less than 30 wt%, the ginsenoside Rg1 is not less than 25 wt%, and the notoginsenoside R1 is not less than 5 wt%. The pH value of the product is 4.5-7.5, the product meets strict physicochemical and microbial standards, the product is packaged by a sodium-calcium glass bottle, and the shelf life is 24 months. The preparation method comprises the following steps: exclusively extracting, purifying, preparing, sterilizing and the like, and realizing quality controllability through an HPLC (High Performance Liquid Chromatography) characteristic chromatogram. The preparation is reasonable in dosage form, the problems of moisture absorption, low bioavailability and the like of a solid preparation are solved, and the active components are easy to absorb and convenient to take. Through research, the health-care tea has the health-care functions of improving hypoxia tolerance and relieving physical fatigue, and is suitable for people with related requirements.

The application discloses a bovine viral diarrhea virus inactivated vaccine containing ginsenoside Rb1 / Rg5-PLGA nanoparticles, and relates to the technical field of biological medicines.The bovine viral diarrhea virus (BVDV) inactivated vaccine comprises inactivated bovine viral diarrhea virus and a vaccine adjuvant; the vaccine adjuvant comprises ginsenoside Rb1 / Rg5-PLGA nanoparticles.The application effectively enhances the application effect of the vaccine by combining the use of PLGA, ginsenoside Rb1 and Rg5, and can cause better humoral immunity and cellular immunity levels, thereby laying a foundation for the development of the BVDV inactivated vaccine for deer.

The application provides a beta-glucosidase mutant and application thereof in production of ginsenoside Rg3, and belongs to the technical field of genetic engineering.The application provides a beta-glucosidase mutant, and the amino acid sequence is shown as SEQ ID NO:1.The application screens a mutant capable of catalyzing the directional conversion of ginsenoside Rb1 into ginsenoside 20(S)-Rg3 through site-directed mutagenesis.Compared with a wild type, the mutant has a mutation site K715G, and the yield of Rg3 produced by enzymolysis of Rb1 is 585.95 muM, while the yield of the wild type is only 441.22 muM, and the efficiency of the directional conversion of ginsenoside Rb1 into ginsenoside 20(S)-Rg3 is significantly improved.

The present application relates to the technical field of compound analysis, and in particular to a quality analysis method of ginseng medicinal materials, comprising the following steps: S100, preparation of a control solution: taking ginsenoside Rg1 control product, ginsenoside Re control product, ginsenoside Rf control product, ginsenoside Rb1 control product, ginsenoside Rc control product, ginsenoside Rb2 control product, ginsenoside Rd control product, 3-O-feruloylquinic acid control product, 4-coumaric acid control product, 8-O-4 / 8-O-4 dehydrogenated tri-ferulic acid control product, and adding methanol to prepare a mixed solution, and shaking to obtain the control solution. The present application synchronously monitors two components of saponins and phenolic acids under one detection method, monitors ten component contents of seven saponin components and three polyphenol components, obtains characteristic spectra of saponin components and polyphenol components, and the monitoring quality is more comprehensive and efficient.

This invention belongs to the field of genetic engineering and biotechnology, specifically relating to a β-glucosidase PO3 for the conversion of rare ginsenosides, its preparation method, and its applications. This invention obtains β-glucosidase PO3 by PCR amplification using genomic DNA of *Xanthomonas pseudoepiplo* TY3-10 as a template. The results of the examples show that this enzyme can not only convert total ginsenosides into rare ginsenosides F2, C-O, C-Mx1, and C-Mc1, but also convert ginsenoside Rb1 into F2, ginsenoside Rb2 into C-O, ginsenoside Rb3 into C-Mx1, and ginsenoside Rc into C-Mc1; it also exhibits excellent catalytic performance and high expression efficiency, possessing extremely high application value and commercial prospects.

The plant lactobacillus PG410, its application and a method for fermentatively converting ginsenoside Rb1 to prepare pseudo-ginsenoside GD belong to the field of fermentation engineering, and the PG410 strain was preserved in China Center for Type Culture Collection (CCTCC) on April 15, 2025, with a preservation number of CCTCC NO: M2025784. After the PG410 strain is prepared into a bacterial suspension, the bacterial suspension is subjected to fermentation culture together with ginsenoside Rb1 to obtain a fermentation product containing pseudo-ginsenoside GD. In the present application, ginsenoside Rb1 is used as a substrate, and the PG410 lactobacillus strain independently isolated and identified is used to fermentatively convert the ginsenoside Rb1, and pseudo-ginsenoside GD is successfully prepared, which fills the technical blank of bio-fermentatively converting ginsenoside Rb1 to prepare pseudo-ginsenoside GD. The preparation method is green, safe and pollution-free, has the advantages of mild reaction and low cost, and provides a theoretical basis for large-scale preparation of pseudo-ginsenoside GD.

This invention discloses a β-glucosidase, its preparation method, and its applications, relating to the field of genetic engineering technology. The amino acid sequence of the β-glucosidase is shown in SEQ ID NO:1. The nucleotide sequence encoding this enzyme, optimized for codon bias in *E. coli*, is shown in SEQ ID NO:2. The constructed recombinant expression vector contains an IPTG inducible promoter, a ribosome binding site, a 6×His tag, a TEV protease recognition site, a flexible linker peptide, and the sequence shown in SEQ ID NO:2. The recombinant expression vector is transformed into *E. coli*, and after induction expression, high-density fermentation, and affinity purification, a highly soluble and active target enzyme is obtained. This enzyme can efficiently catalyze the conversion of ginsenoside Rb1 to rare ginsenoside CK, with a conversion rate exceeding 82%. This invention improves the soluble expression level and preparation efficiency of the target enzyme, making it suitable for industrial production.

The invention discloses a method for preparing ginsenoside Rd through catalysis of L-arabinopyranosidase, which comprises the following steps: taking ginsenoside Rb1 as a substrate, and catalyzing the substrate to be hydrolyzed by using the L-arabinopyranosidase (Uniprot ID (Identity) accession number A0A6I4WC78) from Actinomadura rayonensis) or a mutant of the L-arabinopyranosidase so as to obtain the ginsenoside Rd. According to the method, the high-concentration ginsenoside Rb1 can be efficiently converted under the condition of high-concentration methanol, and industrial production of ginsenoside Rd is promoted.

The application discloses an anti-wrinkle and firming composition suitable for multiple skin types and a preparation method and application thereof, and belongs to the technical field of cosmetics. The composition contains, in mass parts, 2.5-9.5 parts of an active functional component, 5-10 parts of a targeted delivery carrier system and cosmetically acceptable adjuvants. The active functional component is composed of ginsenoside Rb1, green tea extract-white resveratrol compound and asiaticoside-dipotassium glycyrrhizinate compound, and the targeted delivery carrier system is a transdermal peptide modified liposome and a natural nano-structured lipid carrier. The application constructs a double-targeted delivery system according to different skin aging mechanisms and skin characteristics, realizes single formula adaptation to multiple skin types, improves the transdermal efficiency of active ingredients and the targeted enrichment effect on the dermis, has no carrier residue, and multiple components synergistically play the effects of anti-wrinkle and firming, soothing and protection, is safe, and can be widely applied to the preparation of anti-aging skin care products.

The invention belongs to the technical field of biology, and particularly relates to recombinant glucoside hydrolase and application thereof in preparation of rare ginsenoside F2. The recombinant glucoside hydrolase provided by the invention is a further modified product on the basis of specific fusion protein. The recombinant glucoside hydrolase provided by the invention can efficiently catalyze a reaction under a relatively mild condition, and has the characteristics of strong substrate specificity and high conversion rate. In the aspect of reaction efficiency, the enzyme shows excellent catalytic performance: a large amount of ginsenoside Rb1 substrate can be converted into the rare ginsenoside F2 in a short time, the performance is excellent, and the efficient and high-purity preparation of the rare ginsenoside F2 is facilitated.

The application provides a multi-component quantitative analysis method of anti-aging tablets, acetonitrile-0.1% formic acid aqueous solution is used as a mobile phase, an HSS T3 chromatographic column is used for target compound separation, and 13 active components in the anti-aging tablets are simultaneously determined in an MRM mode by using an electrospray ionization triple quadrupole mass spectrometer, the linear range of the 13 active components is 0.4-100 ng / mL, the linear range of ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, ginsenoside Rd, ginsenoside Re, ginsenoside Rf and ginsenoside Rg1 is 4-1000 ng / mL, the method has high sensitivity, strong specificity and good reproducibility, and realizes simultaneous quantitative analysis of the 13 active components in the anti-aging tablets.

The present application belongs to the technical field of cosmetics, and particularly relates to a composition with whitening effect and application thereof. The composition with whitening effect provided by the present application comprises the following components in parts by weight: 13-17 parts of eustigmatophyte extract, 11-15 parts of rosmarine seed oil, and 6-10 parts of hydrolyzed ginsenosides; wherein the hydrolyzed ginsenosides comprise ginsenoside Rb1 and ginsenoside F4; the components in the dosage range defined in the present application synergistically promote the transdermal absorption of active ingredients, effectively improve the tyrosinase inhibition rate, so as to achieve the whitening effect and be mild and non-irritating; the preparation method is simple and easy to operate, has the capacity of large-scale production and the feasibility of industrialization; the preparation method for preparing the serum from the composition is simple and easy to operate, the prepared serum can also significantly improve the L value increase rate and ITA° value increase rate, has the whitening effect, and indicates that the composition has wide market application value in skin care products.

The application discloses a plant lactobacillus gasseri strain capable of transforming ginsenoside and cassia glycoside, and application of the strain in lipid reduction and alleviation of fatty liver, and belongs to the fields of microbial technology, medicine and functional food. The core feature of the strain is that the strain can not only transform ginsenoside Rb1 into ginsenoside Rd with higher activity, but also transform cassia glycoside into cassia glycoside base, thereby improving the efficacy. The animal experiment proves that the strain and the corresponding substrate are combined to play a better role in lipid reduction and liver protection: the serum total cholesterol and triglyceride levels of high-fat diet mice can be effectively reduced, and the liver weight, liver lipid deposition and liver tissue fatty degeneration can be reduced and improved. The strain provides a new core strain and technical scheme for developing microecological preparations for preventing and / or assisting in treating hyperlipidemia, non-alcoholic fatty liver and other metabolic diseases.

The invention discloses a compound melanterite pill specific chromatogram and a construction method and a quality detection method thereof, and belongs to the field of Chinese patent medicine detection. Taking different batches of compound melanterite pills as test articles to prepare a compound melanterite pill test article solution; the method comprises the following steps: taking gallic acid, ginsenoside Rg1, procyanidine B2, cinnamic acid, coumarin, ginsenoside Rh1, cinnamyl alcohol, cinnamaldehyde, arachidonic acid, epicatechin, 2-methoxycinnamic acid, ginsenoside Rb1, ginsenoside Rd, betulinic acid and 5-hydroxymethylfurfural as reference substances to prepare a single reference substance solution; performing chromatographic analysis on the compound melanterite pill test solution and the single reference substance solution, and recording chromatograms; carrying out similarity analysis; and constructing the characteristic chromatogram of the compound melanterite pill according to the chromatogram of the test solution of the compound melanterite pill and the chromatogram of the single reference substance solution in combination with the total ion chromatogram obtained by the high-resolution mass spectrum and the mass spectrum result map of the chemical components. The method can accurately, clearly and objectively evaluate the quality of the compound melanterite pill.

The present application relates to the technical field of nanocarrier, and discloses a multifunctional nanocarrier, a preparation method and application thereof.The multifunctional nanocarrier comprises ginsenoside Rb1 and a cationic polymer, and the cationic polymer is one of polyaminopropyl biguanide PAPB, chitosan CS, polyacrylamide PAM or polyethylenimine PEI.The preparation method is as follows: the ginsenoside is dispersed in physiological saline, a cationic polymer solution is added, and the mixed solution is ultrasonically treated to obtain the multifunctional nanocarrier.The multifunctional nanocarrier, the preparation method and application thereof can specifically target macrophages, can not only promote the macrophage-mediated delivery of Rb1 to the inflammation site in a sepsis-related acute lung injury (ALI) model, relieve inflammation, but also can improve the bacterial clearance rate in blood infection-related ALI and bacterial pneumonia models, reduce inflammation and immune response, and can be used for developing drugs for treating chronic inflammation.

The invention discloses a method for detecting saponin components in ginseng and a preparation thereof. Relates to the field of medicinal material detection. The method for detecting the saponin components in the ginseng and the ginseng preparation comprises the following steps: S1, taking a ginseng sample or a ginseng-containing preparation, adding an extraction solvent, and extracting to obtain a test solution; s2, the test solution is injected into a liquid chromatograph, a chromatographic column is adopted for gradient elution, and octadecylsilane chemically bonded silica is adopted as a filling agent of the chromatographic column; s3, detecting pseudo-ginsenoside F11, ginsenoside Rf, ginsenoside Rg1, ginsenoside Rb1 and ginsenoside Re by adopting an electrospray ionization source negative ion mode and a multi-reaction monitoring mode of a mass spectrometry detector; a mobile phase used for gradient elution is selected from acetonitrile-water, an acetonitrile-ammonium acetate solution, acetonitrile-ammonium formate, methanol-formic acid or an acetonitrile-tetrahydrofuran-ammonium formate solution. By combining C18 chromatographic column gradient elution with a mass spectrum multi-reaction monitoring (MRM) mode and providing a mobile phase system, the problems of narrow applicability, isomeride interference, strong matrix effect and the like of a method for detecting saponin components of ginseng and preparations thereof in the prior art are effectively solved.

A strain of Lactobacillus putrefaction ( Loigolactobacillus coryniformis ZS-07 and its application in the fermentation preparation of rare ginsenosides belong to the field of microbial fermentation. This rod-shaped Lactobacillus putrefactive ( Loigolactobacillus coryniformis ZS-07 was deposited at the China Center for Type Culture Collection on January 4, 2026, with accession number CCTCC NO: M 2026009. This invention uses ginsenoside Rb1 as a raw material and utilizes *Lactobacillus putrefactiveus* (…). Loigolactobacillus coryniformis The ZS-07 fermentation process was used to prepare rare ginsenosides 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5. After fermentation, ginsenoside Rb1 can be converted into 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5. Unlike conventional methods that rely on alkaline hydrolysis, high temperature and high pressure, or steam treatment, this invention's process exhibits excellent mildness, environmental friendliness, and low cost advantages, and can effectively increase the content of the conversion products. This invention provides a new strategy for the targeted synthesis of rare ginsenosides 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5, thereby broadening their application prospects and industrialization potential.